Health-related quality of life effect of mogamulizumab by patient blood involvement
Background: Cutaneous T-cell lymphomas (CTCL) are a rare group of non-Hodgkin lymphomas that present in skin. The most studied subtypes, mycosis fungoides (MF) and S ézary syndrome (SS), together represent around two-thirds of all cases. MF/SS disease staging is multi-compartmental utilising a modified TNMB classification. Leukemic involvement in MF/SS has previously been found to be an independent prognostic factor affecting overall survival, disease-specific survival and increasing risk of disease progression (Agar 2010, Am Soc J Clin Oncol), although further research is ongoing.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Pier Luigi Zinzani, Pablo Ortiz-Romero, Margarida Lima, Auris O. Huen Tags: POSTER PRESENTATIONS: QUALITY OF LIFE Source Type: research
More News: Cancer | Cancer & Oncology | Cutaneous T cell lymphoma | Hodgkin's Disease | Leukemia | Lymphoma | Mycosis Fungoides | Skin | T-cell Lymphoma